Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2010
Filing Date: May 10, 2010
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare, Physician, and IT and Engineering. The company provides contract and permanent staffing solutions.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Revenues | $96.3 million | $116.8 million |
| Gross Profit | $30.8 million | $37.0 million |
| Gross Margin | 32.0% | 31.7% |
| Operating Income | $1.0 million | $3.9 million |
| Net Income (Loss) | $(0.3) million | $1.6 million |
| Diluted EPS | $(0.01) | $0.05 |
| Cash from Operations | $6.4 million | $18.2 million |
| Cash and Equivalents (End of Period) | $30.3 million | $46.5 million |
| Long-Term Debt | $77.9 million | $77.9 million |
| Working Capital | $63.1 million | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 17.5% ($20.5 million) year-over-year due to weakened demand across all segments. The Healthcare segment saw the steepest drop at 41.0%, driven by a 57.7% decline in Nurse Travel revenues.
- Profitability Shift: The company reported a net loss of $0.3 million compared to net income of $1.6 million in the prior year. Operating income fell to $1.0 million from $3.9 million.
- Margin Expansion: Despite revenue declines, consolidated gross margin expanded by 30 basis points to 32.0%, attributed to a shift in revenue mix toward higher-margin segments and reduced employee-related expenses in Healthcare.
- Cash Flow: Operating cash flow decreased significantly to $6.4 million from $18.2 million, reflecting lower earnings and changes in working capital.
- Debt Status: Long-term debt remained stable at $77.9 million. The company paid down $48.0 million of its term loan in 2009 and is currently in compliance with all financial covenants.
Outlook, Risks, and Management Commentary
- Market Conditions: Management notes that labor markets remain weak, though early signs of recovery were seen in IT/Engineering and Life Sciences in Q1 2010. Healthcare demand is expected to stabilize in Q2 2010.
- Goodwill Impairment: Management performed a Step 1 goodwill impairment test for the Nurse Travel and Physician reporting units due to operating results falling below forecasts. No impairment was recorded; the estimated fair value exceeded carrying value by 30.9% (Nurse Travel) and 33.1% (Physician).
- Future Forecasts: The company does not anticipate returning to historical revenue highs for five to six years. Revenue growth is forecasted to stabilize in Q4 2010, with growth rates in 2011 reflecting a recovery from the recession.
- Risks: Key risks include the continued impact of the global economic slowdown, uncertainty surrounding healthcare reform, and the sensitivity of fair value estimates to changes in discount rates or cash flow projections.
- Subsequent Event: On April 19, 2010, the company acquired Cambridge Group Ltd. for $5.5 million in cash plus potential earn-outs.
Investor Verification Checklist
- Debt Covenants: Verify continued compliance with the 3.00:1.00 maximum total leverage ratio and 4.00:1.00 minimum interest coverage ratio required by the credit facility.
- Healthcare Segment Recovery: Monitor the stabilization of the Nurse Travel segment, which has seen significant sequential declines and represents a material portion of goodwill risk.
- Goodwill Sensitivity: Review the sensitivity of goodwill valuations to changes in discount rates (less than 500 basis points) and cash flow projections (less than 30% decline) which could trigger impairment.
- Acquisition Integration: Assess the financial impact and integration progress of the Cambridge Group Ltd. acquisition announced in April 2010.
- Stock-Based Compensation: Note the $1.3 million expense in Q1 2010 and the performance-based vesting conditions tied to adjusted EBITDA targets for executive compensation.